Eisai presented latest data from the lecanemab clinical program at AAIC 2021
Go back to Eisai presented latest data from the lecanemab clinical program at AAIC 2021| BARNES GROUP, Inc. (NYSE: B) | Delayed: 36.26 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $36.26 | 52 Week High | $44.27 | |||
| Open | $36.26 | 52 Week Low | $30.07 | |||
| Day High | $36.26 | P/E | 27.68 | |||
| Day Low | $36.26 | EPS | $1.31 | |||
| Volume | 129 | |||||
| BIOAMBER, Inc. (NYSE: BIOA) | Delayed: 0.16 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.16 | 52 Week High | $8.73 | |||
| Open | $46.41 | 52 Week Low | $2.86 | |||
| Day High | $0.16 | P/E | N/A | |||
| Day Low | $0.16 | EPS | $-3.82 | |||
| Volume | 1,375,961 | |||||
